The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
Blaze, combined with the experience of CTx, makes a powerful and effective platform for lead discovery.
Read the rest of entry »
Evotec has made a € 15 M investment to take a minority stake in Exscientia.
Global pharmaceutical and healthcare company, has exercised its license option to Arecor’s proprietary formulation technology, to develop differentiated biosimilar products.
LiDia™ Bloodstream Infection (BSI) Test showcased at an Imperial College/Royal Institution Technology vs Infectious Diseases Summit, London
AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards.
Wickham Laboratories reports a successful completion of the MHRA audit process and the subsequent renewal of GMP accreditation.
This is the Company’s second orally-active small molecule cancer therapeutic agent to enter clinical trials during the past 12 months.
The proposals led by eligible STFC scientists will provide solutions to address the healthcare grand challenges using STFC science, technologies and skills. User engagement is encouraged.
Replimune Group Inc. announced today a key addition to its senior leadership team as it progresses its Immulytic™ oncolytic immunotherapy platform rapidly towards clinical trials.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.